Also trades as: XTLB.TA (TLV) · $vol 0M
XTLB NASDAQ
XTL Biopharmaceuticals Ltd.
1W: -7.8%
1M: -0.8%
3M: +184.6%
YTD: +315.4%
1Y: +126.4%
3Y: +104.1%
5Y: -25.2%
$2.51
-0.03 (-1.18%)
Weekly Expected Move ±32.0%
$1
$2
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$5.9M
52W Range2.12-10.28
Volume25,250
Avg Volume1,888,898
Beta0.71
Dividend—
Analyst Ratings
Company Info
CEONoam Band
Employees10
SectorHealthcare
IndustryBiotechnology
IPO Date2005-09-01
Websitextlbio.com
5 Badner Street
Ramat Gan 5218102
IL
Ramat Gan 5218102
IL
972 3 611 6600
About XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Latest News
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
Crude Oil Jumps 5%; Automatic Data Processing Posts Upbeat Earnings
Dow Falls 100 Points; Brinker Earnings Beat Estimates
XTL Biopharmaceuticals to acquire Psyga Bio in all-stock deal; shares surge
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Segal Niv | 0 | — | 2026-03-18 | |
| EDELMAN JOSEPH | S-Sale | 9,600,000 | $0.15 | 2008-11-19 |
| EDELMAN JOSEPH | S-Sale | 24,681,360 | $0.14 | 2008-11-18 |
| EDELMAN JOSEPH | S-Sale | 2,696,450 | $0.15 | 2008-11-18 |
| EDELMAN JOSEPH | S-Sale | 29,740 | $0.16 | 2008-11-18 |